Ocean biomedical, inc. announces receipt of notice from nasdaq regarding late filing of quarterly report on form 10-q

Providence, rhode island, may 30, 2024 (globe newswire) -- ocean biomedical, inc. (nasdaq: ocea), today announced that on may 22, 2024, it received a notice from the nasdaq stock market llc (“nasdaq”) stating that because the company has not yet filed its quarterly report on form 10-q for the period ended march 31, 2024 (the “form 10-q”), the company is not in compliance with nasdaq listing rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the securities and exchange commission (the “sec”).
NDAQ Ratings Summary
NDAQ Quant Ranking